Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Fort Wayne. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in Fort Wayne at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
The goal of this FID-007 Clinical Trial is to compare the efficacy of different dosing regimens of FID-007 in combination with Cetuximab in patients with recurrent or metastatic Head and Neck Squamous Cell Carcinoma (HNSCC). The main questions it aims to answer are: to evaluate the efficacy, and to characterize the safety and tolerability. Eligible participants will be enrolled and randomized to 1 of 2 arms of FID-007 with fixed-dose Cetuximab in each 28-day cycle.
Sponsor: Fulgent Pharma LLC.
Check if you qualify for this head and neck cancer clinical trial in Fort Wayne, IN
If you're searching for head and neck cancer treatment options in Fort Wayne, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fort Wayne research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.